Bacterial clade-specific analysis identifies distinct epithelial responses in inflammatory bowel disease

Cell Rep Med. 2023 Jul 18;4(7):101124. doi: 10.1016/j.xcrm.2023.101124.

Abstract

Abnormal immune responses to the resident gut microbiome can drive inflammatory bowel disease (IBD). Here, we combine high-resolution, culture-based shotgun metagenomic sequencing and analysis with matched host transcriptomics across three intestinal sites (terminal ileum, cecum, rectum) from pediatric IBD (PIBD) patients (n = 58) and matched controls (n = 42) to investigate this relationship. Combining our site-specific approach with bacterial culturing, we establish a cohort-specific bacterial culture collection, comprising 6,620 isolates (170 distinct species, 32 putative novel), cultured from 286 mucosal biopsies. Phylogeny-based, clade-specific metagenomic analysis identifies key, functionally distinct Enterococcus clades associated with either IBD or health. Strain-specific in vitro validation demonstrates differences in cell cytotoxicity and inflammatory signaling in intestinal epithelial cells, consistent with the colonic mucosa-specific response measured in patients with IBD. This demonstrates the importance of strain-specific phenotypes and consideration of anatomical sites in exploring the dysregulated host-bacterial interactions in IBD.

Keywords: Enterococcus; cell death; epithelial cells; gastrointestinal tract; host-microbe interactions; inflammatory bowel disease; metagenomic; microbiome; pediatric IBD; ulcerative colitis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biopsy
  • Colon / pathology
  • Epithelial Cells / pathology
  • Humans
  • Inflammatory Bowel Diseases* / genetics
  • Intestinal Mucosa / microbiology